A Zero-Disruption 3PL Lift and Shift: Scaling Complex Product Distribution with a Seamless 3PL Transition
As a leading biopharmaceutical company experienced rapid market adoption, it needed a 3PL logistics partner that could scale with its growth and navigate the complexities of controlled substance distribution. The company’s previous partner, one of the industry’s largest logistics providers, used a rigid logistics framework that caused significant operational friction. This lack of flexibility restricted the company’s ability to secure su ccient inventory, creating challenges in meeting market demand during periods of sales growth.
CareTria delivered a configurable, end-to-end pharmaceutical 3PL solution using a zero-disruption transition model. A strategic implementation plan executed a seamless weekend cutover with no lost sales. This flawless lift and shift enabled the client to scale their product toward significant annual revenue milestones.
A four-phase methodology was used to map, build, test, and execute the transition.
Discovery and Design: Discovery sessions were initiated to document exact requirements, map
current workflows, and tailor Standard Operating Procedures (SOPs) to the client’s needs.
Build and Integration: All Electronic Data Interchange (EDI) and Electronic Product Code Information Services (EPCIS) connections were established, integrating directly with the client’s Enterprise Resource Planning (ERP) and Warehouse Management System (WMS) to build customized reporting dashboards for improved visibility.
Testing and Readiness: Rigorous end-to-end testing of all financial and operational systems,
including pricing, chargebacks, and invoicing, validated every mechanism before go-live.
Go-Live and Hypercare: The transition was executed over a single weekend using a controlled cutover strategy, followed by a hypercare phase to actively monitor all systems and ensure stability.
A Seamless Transition Strategy
CareTria executed a smooth transition built on operational redundancy, proactive partner alignment,
and rigorous pre-launch validation, ensuring no disruption to patient access or revenue.
- Inventory and Order Continuity: Safety stock was established, a dual inventory system operated
in parallel with the legacy provider, and orders were preloaded to ensure continuous product flow
and immediate fulfillment post-transition. - Financial Integrity: All financial mechanisms, including pricing, chargebacks, and invoicing,
were rigorously tested and validated pre-launch to prevent revenue leakage and ensure
accurate order-to-cash cycles. - Executive-Level Governance: Direct involvement from senior leadership provided immediate
decision-making to keep the project on schedule and on budget. - Proactive Customer and Partner Alignment: Downstream communications with end customers
and partners were managed to ensure the transition was seamless and felt only as an improvement
in service. - Redundant Operations: Running dual operations and parallel validation alongside the legacy
provider before cutover allowed for the identification and resolution of potential friction points
in a controlled environment, ensuring a stable go-live
The Results
- Uninterrupted Patient Access: The 3PL transition yielded zero disruption to orders, shipments, or revenue. Continuous supply of vital medication was maintained.
- Complete Sales Capture: Through safety stock, dual inventory, and preloaded orders, every single sale was captured during the transition window.
- Rapid Scalability: The successful integration immediately supported a product on track to reach significant annual sales milestones.
- Operational Agility: CareTria delivered a configurable logistics model that now seamlessly accommodates sudden order changes and shifting delivery preferences without halting operations.
- Enhanced Visibility: Real-time, unified order-to-cash visibility was gained through tailored dashboards, entirely eliminating the blind spots experienced with previous providers.
By replacing a rigid logistics framework with CareTria’s highly configurable 3PL model, the client overcame complex distribution challenges and scaled operations without friction. Our high-touch,
personal engagement model proved that transitioning 3PL providers does not have to be a risk. When managed effectively, it is a strategic advantage
Uninterrupted Patient Access:
The transition yielded zero disruption to orders, shipments, or revenue. Continuous supply of vital medication was maintained
Complete Sales Capture:
Through safety stock, dual inventory, and preloaded orders, every single sale was captured during the transition window
Rapid Scalability:
The successful integration immediately supported a product on track to reach significant annual sales milestones
